MAR 12, 2020 6:48 PM PDT

Recent Data Accelerates Coronavirus SARS-CoV2 Drug Discovery

WRITTEN BY: Nouran Amin

Coronavirus (SARS-CoV-2) is a currently a human health crisis. It is not only highly infectious but results severe pneumonia (COVID-19) in some cases. Now, researchers by Prof. Dr. Rolf Hilgenfeld, University of Lübeck, have found an effective approach to studying the coronavirus by using high-intensity X-ray light from the Berlin synchrotron source BESSY II. They analyzed the 3D shape of the main protease (Mpro or also 3CLpro) of SARS-CoV-2. This protein plays a central role for maintaining the virus’s reproductive capability.

Learn more about COVID-19:

Since the world is scrambling to find treatments that work against the SARS-CoV-2, understanding the architecture of the protein is critical to identify specific areas of attack—thus, advancing drug discovery

"For such issues of highest relevance, we can offer fast track access to our instruments," says Dr. Manfred Weiss, who heads the Research Group Macromolecular Crystallography (MX) at HZB.

The high-intensity X-ray light from the BESSY II facility of the Helmholtz-Zentrum Berlin make the images of the 3D architecture of the protein molecules more clear.

“The 3D architecture provides concrete starting points for developing active substances or inhibitors. These drugs could dock specifically to target points of the macromolecule and impede its function,” says Rolf Hilgenfeld is an expert in the field of virology and already developed an inhibitor against the SARS-virus during the 2002/2003 SARS pandemic.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 15, 2020
Cannabis Sciences
Could Cannabis Help in the Opioid Crisis?
DEC 15, 2020
Could Cannabis Help in the Opioid Crisis?
While cannabis is increasingly available for medicinal use, doctors largely remain unable to prescribe it to their patie ...
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
JAN 24, 2021
Cannabis Sciences
Cannabis Compound CBD Shows Promise as Antibiotic
JAN 24, 2021
Cannabis Compound CBD Shows Promise as Antibiotic
Researchers from the University of Queensland, in collaboration with Botanix Pharmaceuticals Limited, have found that ca ...
JAN 20, 2021
Drug Discovery & Development
Designer Cytokine: Potential Therapeutic Approach for Paralysis
JAN 20, 2021
Designer Cytokine: Potential Therapeutic Approach for Paralysis
Paralysis due to spinal cord damage remains an irreparable condition. However, a new therapeutic approach may bring rene ...
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
FEB 10, 2021
Drug Discovery & Development
Ketamine Reduces Suicidal Thoughts in Patients with Depression
FEB 10, 2021
Ketamine Reduces Suicidal Thoughts in Patients with Depression
Ketamine has been known for some time for its ability to tackle depression. Now, however, researchers have found that or ...
Loading Comments...